Physician profile

Ralph J Torrence

Urology · Saint Louis, MO

NPI 1861501579

$1,857.23

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$476.57

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $1,121.58 2019-2024 Lumenis Pulse 120h, Lithovue, Moses 550 Dfl
Teleflex LLC $202.97 2021-2024 Urolift
Coloplast Corp $129.39 2019
Karl Storz Endoscopy-America $126.54 2019-2023 N.A.
Genzyme Corporation $122.21 2019
Procept Biorobotics Corporation $96.64 2024 Aquabeam System
Photocure INC $57.90 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ralph J Torrence

$1,857.23

in general payments reported 2019-2025

Years
2019-2024
Top company
Boston Scientific Corporation

https://glasscript.com/doctor/311136/ralph-j-torrence

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.